Scientists have achieved a major milestone in the quest to understand high-temperature superconductivity in hydrogen-rich ...

The device is designed to lower blood pressure while simultaneously modulating the autonomic nervous system by delivering ...

If you have high blood pressure, you'll want to be mindful of your numbers and stick to this type of exercise.

But for some women, the postpartum journey can include unexpected health challenges—one of which is postpartum hypertension. While it may sound alarming, understanding this condition can go a ...

Managing hypertension with medication can mitigate dementia risk but does not eliminate it. Researchers do not fully understand the direct causes of hypertension, Daugherty said. “Our current ...

Corpus Christi Water says they are aware of the smell after receiving reports from residents. US Jobs Growth Explodes in Major Win For Trump Supreme Court sides with Trump on blocking DEI-related ...

Glycosuria occurs when excess blood sugar (glucose) is passed into the urine. Normally, your kidneys absorb the sugar from any liquid passing through them, but with glycosuria, the kidneys don’t ...

It is not just breastfeeding issues and sleepless nights after childbirth, new moms also struggle with a series of postpartum problems including hypertension. Postpartum hypertension is a growing ...

Keeping an eye on the blood pressure is also important, as there is a chance of ending up with postpartum hypertension. It refers to high blood pressure that new moms can face soon after pregnancy. It ...

Correspondence to: Dr. Ping Zou, School of Nursing, Nipissing University, 750 Dundas Street West, Toronto, Ontario M6J 3S3, Canada. Tel/Fax: (+1) 416-642-7003.

CHICAGO — The addition of lorundrostat, an investigational drug, to the treatment regimen of people with well-treated but uncontrolled and resistant hypertension could be beneficial, new data show.

The Advance-HTN trial showed that lorundrostat effectively lowered 24-hour SBP at 12 weeks among patients with uncontrolled and treatment-resistant hypertension vs. placebo. Participants at 103 U.S.